News

RNAi Candidate in Development for Coronavirus

RNAi Candidate in Development for Coronavirus

Alnylam and Vir Biotechnology are working on an anti-SARS-CoV-2 inhaled RNAi candidate, which is expected to begin in-human testing by the end of the year. Yourway is equipped to handle all clinical trials, including our ongoing direct-to-patient services.

Back to Index
Media

Upcoming Event

BIO International Convention

June 8-11, 2020
San Diego, CA, USA (Virtual)

Media

Articles

SUPPLY CHAIN SOLUTIONS – Storage and Distribution Support for Clinical Trials Worldwide

Open chat
Come chat with us!
Hello! How can I help you?